Updated
Reviewed
Aug. 01, 2019
Appendix B: Panel Roster and Financial Disclosures
Human Papillomavirus
| Member | Financial Disclosure | ||
|---|---|---|---|
| Company | Relationship | ||
| Brown, Darron | Indiana University School of Medicine | Merck | Research Support |
| Productive Data Solutions, Inc. | Consultant | ||
| Cu-Uvin, Susan* | Brown University | AIDS Malignancy Consortium | Data Safety Monitoring Board |
| National Institutes of Health | Research Support | ||
| United Nations Population Fund | Research Support | ||
| Dunne, Eileen | Centers for Disease Control and Prevention | None | N/A |
| Einstein, Mark | Rutgers New Jersey Medical School | Advaxis | Research Support |
| Altum Pharma | Consultant | ||
| AstraZeneca | Research Support | ||
| Becton-Dickinson | Consultant | ||
| Cynvec | Consultant | ||
| Hologic | Consultant | ||
| Inovio | Research Support | ||
| J&J | Research Support | ||
| Merck | Consultant | ||
| Papivax | Consultant | ||
| PDS Biotechnologies | Advisory Board | ||
| Pfizer | Research Support | ||
| Roche | Research Support | ||
| Massad, L. Stewart | Washington University School of Medicine | None | N/A |
| Moscicki, Anna Barbara | University of California, Los Angeles | Antiva | Advisory Board |
| GlaxoSmithKline | Advisory Board | ||
| Merck | Advisory Board | ||
| Patient-Centered Outcomes Research Institute | Research Support | ||
| Palefsky, Joel | University of California, San Francisco | Antiva Biosciences | Research Support |
| Janssen Pharmaceuticals | Speakers Bureau | ||
| Merck | Advisory Board, Research Support | ||
| Ubiome | Advisory Board, Equity Interest | ||
| Vir Biotechnology | Consultant, Equity Interest | ||
| Virion Therapeutics | Advisory Board, Equity Interest | ||
| Stier, Elizabeth | Boston University Medical Center | Antiva | Consultant |
| Inovio | Research Support | ||
| National Institutes of Health | Research Support | ||
| Strickler, Howard | Albert Einstein College of Medicine | None | N/A |
| Weiser, John | Centers for Disease Control and Prevention | None | N/A |
| Wilkin, Timothy | Weill Cornell Medical College | GlaxoSmithKline/ViiV | Consultant, Research Support |
| * Group lead Note: Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019. |
|||
Download Guidelines
- Section OnlyPDF (337.79 KB)
- Full GuidelinePDF (3.78 MB)
- Tables OnlyPDF (481.21 KB)